Argyrins, immunosuppressive cyclic peptides from myxobacteria - I. Production, isolation, physico-chemical and biological properties

被引:88
作者
Sasse, F
Steinmetz, H
Schupp, T
Petersen, F
Memmert, K
Hofmann, H
Heusser, C
Brinkmann, V
Von Matt, P
Hofle, G
Reichenbach, H
机构
[1] Gesell Biotechnol Forsch mbH, Abt Nat Stoffbiol, D-38124 Braunschweig, Germany
[2] Gesell Biotechnol Forsch mbH, Abt Nat Stoffchem, D-38124 Braunschweig, Germany
[3] Novartis Pharma AG, Dept Res, CH-4002 Basel, Switzerland
关键词
D O I
10.7164/antibiotics.55.543
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
A group of cyclic peptides consisting of 8 amino acid residues, named argyrins A to H, were isolated from the culture broth of strains of the myxobacterium Archangium gephyra. Argyrin B was found to be a potent inhibitor of T cell independent antibody formation by murine B cells, and strongly inhibited the two way murine mixed lymphocyte reaction. All argyrins had slight antibiotic activity, especially against Pseudomonas sp., and inhibited growth of mammalian cell cultures. The growth inhibition was often incomplete and varied highly with different cell lines.
引用
收藏
页码:543 / 551
页数:9
相关论文
共 20 条
[1]  
BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
[2]  
BRINKMANN V, 1995, J IMMUNOL, V154, P3078
[3]   Somatostatin receptors and the potential use of Sandostatin® to interfere with vascular remodelling [J].
Bruns, C ;
Shi, V ;
Hoyer, D ;
Schuurman, H ;
Weckbecker, G .
EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2000, 143 :S3-S7
[4]  
Diamond L E, 1999, Expert Opin Investig Drugs, V8, P609, DOI 10.1517/13543784.8.5.609
[5]  
INMAN JK, 1975, J IMMUNOL, V114, P704
[6]   Discordant organ xenotransplantation in primates - World experience and current status [J].
Lambrigts, D ;
Sachs, DH ;
Cooper, DKC .
TRANSPLANTATION, 1998, 66 (05) :547-561
[7]   Role of IL-13 in CD4 T cell-dependent IgE production in atopy [J].
Levy, F ;
Kristofic, C ;
Heusser, C ;
Brinkmann, V .
INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY, 1997, 112 (01) :49-58
[8]  
MORGAN EL, 1983, J IMMUNOL, V130, P1066
[10]  
PIKE BL, 1984, J IMMUNOL, V132, P1687